结合姿势深度调节可光开关联体在5-HT2A受体的有效性
Verena Weber1,2, Giacomo Salvadori3, Federico Natale1,2
1RWTH Aachen University, Aachen, Germany.
Communications chemistry
|February 12, 2026
概括
预测光开关联体的有效性是很困难的. 在色胺5-HT2A受体结合口袋中插入连接体的深度,而不仅仅是结构,决定了受体激活和信号控制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 结构生物学 结构生物学
背景情况:
- 光开关联体通过cis-trans异构化提供受体信号的光控制调制.
- 预测微小的结构变化如何影响G蛋白结合受体 (GPCRs) 的连接体有效性是复杂的.
研究的目的:
- 调查甲基替代剂位置对基于亚博烯的5-HT2A受体连接体疗效的影响.
- 通过计算模拟,阐明差异性联结体有效性的基础分子机制.
主要方法:
- 用分子动力学 (MD) 模拟来研究两个具有para-vs-meta-methoxy组的亚博烯配体.
- 分析的重点是连接体-受体相互作用,结合姿势,和插入深度在orthosteric口袋.
主要成果:
- 帕拉-甲基连接物 (1) 显示对抗激素切换,而元甲基连接物 (2) 保持激素活性.
- 结合体插入深度,受 methoxy 位置和特定残留物相互作用 (如 Asp231, Thr160) 的影响,确定有效性.
- 在trans-1中,Para-methoxy组导致了更深的定和非活性受体稳定; cis-2通过更深的口袋透实现了更高的疗效.
结论:
- 接体插入深度是可光切换接体在5-HT2A受体有效性的关键决定因素.
- 这些发现为设计具有可调光依赖信号特性的GPCR配体提供了框架.
相关概念视频
Ligand Binding Sites
11.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.9K
Ligand Binding and Linkage
4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Cooperative Allosteric Transitions
7.4K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.4K
Drug-Receptor Interactions
8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K


